Groupe La Francaise Gilead Sciences, Inc. Transaction History
Groupe La Francaise
- $6.19 Trillion
- Q2 2025
A detailed history of Groupe La Francaise transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Groupe La Francaise holds 35,490 shares of GILD stock, worth $4.28 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
35,490
Previous 2,264
1467.58%
Holding current value
$4.28 Million
Previous $252 Million
1456.96%
% of portfolio
0.06%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,338Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.13 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.58 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.52 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...